Literature DB >> 6830268

Diagnostic and prognostic value of fibrin stabilising factor in Schönlein-Henoch syndrome.

B Dalens, P Travade, A Labbé, M J Bezou.   

Abstract

Fibrin stabilising factor (FSF) was studied in the circulating blood of 196 children. These 196 children comprised three groups: 131 controls (group A), 20 children with diseases of potential repercussion on FSF determination (group B), and 45 children with Schönlein-Henoch syndrome (group C). Determinations from groups A and B produced normal values, but results from group C were significantly lower at the onset of the vasculitis. Seventeen children with Schönlein-Henoch syndrome have had complications, in 7 of whom these were severe. The decrease in FSF levels was correlated with the severity of such complications, and an increase in FSF was associated with recovery. Determination of FSF activity appears to help in the diagnosis of Schönlein-Henoch vasculitis, as well as helping to monitor the course of the disease and assessing the risks of complications.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830268      PMCID: PMC1628149          DOI: 10.1136/adc.58.1.12

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency.

Authors:  F DUCKERT; E JUNG; D H SHMERLING
Journal:  Thromb Diath Haemorrh       Date:  1960-12-15

2.  [A quantitative determination of factor 13 with anti-factor 13 serum].

Authors:  H Bohn; H Haupt
Journal:  Thromb Diath Haemorrh       Date:  1968-07-31

3.  Factor XIII (fibrin stabilising factor) in Henoch-Schönlein's purpura.

Authors:  P Henriksson; U Hedner; I M Nilsson
Journal:  Acta Paediatr Scand       Date:  1977-05

4.  [The prognostic value of factor XIII in Schönlein-Henoch purpura in childhood (author's transl)].

Authors:  B Dalens; M J Bezou; P Goumy; F Déméocq; G Menut
Journal:  Arch Fr Pediatr       Date:  1980-02

5.  Generalized proteolysis in a young woman with Weber-Christian disease (nodular nonsuppurative panniculitis).

Authors:  P Henriksson; U Hedner; I M Nilsson; P G Nilsson
Journal:  Scand J Haematol       Date:  1975-06
  5 in total
  7 in total

Review 1.  The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.

Authors:  J F Knight
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

Review 2.  Gastrointestinal manifestations of Henoch-Schonlein Purpura.

Authors:  Ellen C Ebert
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

3.  Carbamazepine-induced thrombocytopenia and leucopenia complicated by Henoch-Schönlein purpura symptoms.

Authors:  K Kaneko; J Igarashi; Y Suzuki; S Niijima; K Ishimoto; K Yabuta
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

4.  von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura.

Authors:  D De Mattia; R Penza; P Giordano; G C Del Vecchio; G Aceto; M Altomare; F Schettini
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

5.  Increased risk of renal biopsy complications in patients with IgA-nephritis.

Authors:  Björn Peters; Bernd Stegmayr; Yvonne Andersson; Henrik Hadimeri; Johan Mölne
Journal:  Clin Exp Nephrol       Date:  2015-05-08       Impact factor: 2.801

6.  Laboratory markers indicating gastrointestinal involvement of henoch-schönlein purpura in children.

Authors:  Jeana Hong; Hye Ran Yang
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-03-30

7.  Successful Treatment of IgA Vasculitis Complicated with Bowel Perforation and Crescentic Glomerulonephritis by Combination Therapy of Glucocorticoid, Cyclosporine and Factor XIII Replacement.

Authors:  Keiko Koshiba; Sei Muraoka; Toshihiro Nanki; Satoru Komatsumoto
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.